Edwards MH, Dennison EM, Aihie Sayer A, Fielding R, Cooper C (2015) Osteoporosis and sarcopenia in older age. Bone 80:126–130. https://doi.org/10.1016/j.bone.2015.04.016
Narici MV, Maffulli N (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139–159. https://doi.org/10.1093/bmb/ldq008
Teng Z et al (2021) The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls. Osteoporos Int. https://doi.org/10.1007/s00198-021-05963-x
Wang Y-J et al (2015) Sarco-Osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol 2015:482940. https://doi.org/10.1155/2015/482940
Fahimfar N et al (2020) Prevalence of osteosarcopenia and Its Association with cardiovascular risk factors in iranian older people: bushehr elderly health (BEH) program. Calcif Tissue Int 106(4):364–370. https://doi.org/10.1007/s00223-019-00646-6
Boersma P, Black LI, Ward BW (2020) Prevalence of multiple chronic conditions among US adults, 2018. Prev Chronic Dis 17:200130. https://doi.org/10.5888/pcd17.200130
Timmis A, Townsend N, Gale CP et al (2020) Corrigendum to: European society of cardiology: cardiovascular disease statistics 2019. Eur Heart J 41(47):4507–4507. https://doi.org/10.1093/eurheartj/ehaa062
Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M (2017) Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health 46(4):506–516
WHO Cvd Risk Chart Working Group (2019) World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Heal 7(10):e1332–e1345. https://doi.org/10.1016/S2214-109X(19)30318-3
Sarrafzadegan N, Mohammmadifard N (2019) Cardiovascular disease in Iran in the Last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 22(4):204–210
Shafiee G et al (2017) Bushehr elderly health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open 7(8):e013606. https://doi.org/10.1136/bmjopen-2016-013606
Roberts HC et al (2011) A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 40(4):423–429. https://doi.org/10.1093/ageing/afr051
Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–85
Kanis JA et al (2013) Standardising the descriptive epidemiology of osteoporosis: recommendations from the epidemiology and quality of life working group of IOF. Osteoporos Int 24(11):2763–2764. https://doi.org/10.1007/s00198-013-2413-7
Cruz-Jentoft AJ et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16–31. https://doi.org/10.1093/ageing/afy169
Chen L-K et al (2014) Sarcopenia in Asia: consensus report of the Asian working group for Sarcopenia. J Am Med Dir Assoc 15(2):95–101. https://doi.org/10.1016/j.jamda.2013.11.025
Grundy SM et al (2018) AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: a report of the american college of cardiology/american heart association task force on clinical practice guidelines”. Circulation 139:25. https://doi.org/10.1161/CIR.0000000000000625
Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE (2012) Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. Springer, Berlin
Jewell Nicholas P (2004) Statistics for epidemiology. Chapman & Hall/CRC, Boca Raton
Xia M-F et al (2021) Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: a cross-sectional study. Clin Nutr 40(2):571–580. https://doi.org/10.1016/j.clnu.2020.06.003
Gao K et al (2022) Association between sarcopenia and cardiovascular disease among middle-aged and older adults: findings from the China health and retirement longitudinal study. eClinicalMedicine 44:101264. https://doi.org/10.1016/j.eclinm.2021.101264
Chin SO et al (2013) Sarcopenia is independently associated with cardiovascular disease in older korean adults: the Korea national health and nutrition examination survey (KNHANES) from 2009. PLoS One 8(3):e60119. https://doi.org/10.1371/journal.pone.0060119
Stevenson JC (1990) Osteoporosis and cardiovascular disease in women: converging paths? Lancet 336(8723):1121–1122. https://doi.org/10.1016/0140-6736(90)92590-E
Lampropoulos CE, Papaioannou I, D’Cruz DP (2012) Osteoporosis—a risk factor for cardiovascular disease? Nat Rev Rheumatol 8(10):587–598. https://doi.org/10.1038/nrrheum.2012.120
Rodríguez-Gómez I et al (2022) Osteoporosis and Its Association With Cardiovascular Disease, Respiratory Disease, and Cancer: Findings From the UK Biobank Prospective Cohort Study. Mayo Clin Proc 97(1):110–121. https://doi.org/10.1016/j.mayocp.2021.07.019
Pechmann LM, Petterle RR, Moreira CA, Borba VZC (2021) Osteosarcopenia and trabecular bone score in patients with type 2 diabetes mellitus. Arch Endocrinol Metab. https://doi.org/10.20945/2359-3997000000418
Chen X et al (2019) Association between osteosarcopenic obesity and hypertension among four minority populations in China: a cross-sectional study. BMJ Open 9(7):e026818. https://doi.org/10.1136/bmjopen-2018-026818
Sasaki K et al (2020) The prevalence of sarcopenia and subtypes in cardiovascular diseases, and a new diagnostic approach. J Cardiol 76(3):266–272. https://doi.org/10.1016/j.jjcc.2020.03.004
留言 (0)